DXR Q4 2025 Earnings — Daxor Corporation Revenue & Financial Results | Market Cap Arena

DXRDaxor Corporation

$58M

Q4 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$131,846-81.0% YoY

Gross Profit

-$104,635-79.4% margin

Operating Income

$10M7237.9% margin

Net Income

$10M7235.3% margin

EPS (Diluted)

$1.89

Cash Flow

Operating Cash Flow

-$297,466

Free Cash Flow

-$297,470

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$46M

Total Liabilities

$122,595

Stockholders' Equity

$46M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$131,846	$695,307	-81.0%
Gross Profit	-$104,635	$620,663	-116.9%
Operating Income	$10M	$2M	+332.7%
Net Income	$10M	$2M	+340.2%